
%20(1).jpg)
How Freya Meds Scaled to $3M+/mo profitably in the US Market.
When Freya Meds came to Scale Digital, they were generating around $300K per month - a solid low 7-figure revenue base, but well below their potential. The problems ran deep: their Meta account structure was inefficient, tracking and analytics were unreliable, the website wasn't built to convert, and creative direction lacked a clear, performance-driven strategy. Without clean data and the right infrastructure, scaling profitably wasn't just difficult - it was impossible.
Rebuilt the Meta account architecture from the ground up - restructuring campaigns, consolidating ad sets, and implementing a framework designed for aggressive, profitable scaling.
Shifted away from underperforming creative and guided Freya Meds toward high-impact, conversion-driven content - the kind of ads that win auctions and move customers to act.
Cleaned up pixel tracking, analytics, and attribution so every dollar of spend was measurable - giving us the confidence to scale without flying blind.
The website and developer infrastructure weren't part of the original engagement - but they were holding everything back. Scale's team connected Freya Meds with a highly skilled developer, worked closely alongside them to rebuild the site for conversion, and treated every problem as their own. The result was a brand that was finally ready to scale from end to end.
Within six months, Freya Meds went from $300K/mo to over $3M+/mo in the US market - a 1,100% increase - while maintaining a profitable customer acquisition cost. What started as a media buying engagement became a full partnership: strategy, creative, data, and development all working in lockstep.
"Scale's responsiveness and comprehensive knowledge of current strategies were invaluable to us. They feel like an extension of our in-house team. We're excited for what the future holds and couldn't be happier with the results so far."
- Luke Marshall, Freya Meds

